Q&A: Confirming Next-Gen Sequencing Results with Sanger
Tracy Vence | Oct 11, 2016
Ambry Genetics CEO Aaron Elliott discusses his team’s recent analysis of 20,000 clinical next-generation sequencing panels.
Who Is Immune to Zika?
Amanda B. Keener | Oct 11, 2016
Researchers tap into ongoing dengue studies to improve antibody-based diagnostic tests for Zika and address unanswered questions about the emerging virus’s epidemiology.
New Lyme Disease Test Developed by Summer Student
Jenny Rood | Aug 1, 2016
The high schooler was studying cancer biomarkers in a George Mason University lab when her familial experiences with Lyme disease sparked an idea.
Banking on Blood Tests
Jyoti Madhusoodanan | Apr 1, 2016
How close are liquid biopsies to replacing current diagnostics?
FDA: Lab Tests Can Cause Harm
Tracy Vence | Nov 17, 2015
The US Food and Drug Administration cites cases in which laboratory-developed tests “may have caused or have caused actual harm to patients.”
Exomes in the Clinic
Tracy Vence | Oct 21, 2014
Two teams report molecular diagnosis rates of 25 percent sequencing separate sets of patients with undiagnosed, suspected genetic conditions.
High-Tech Yogurt Could Detect Disease
Molly Sharlach | Oct 16, 2014
Nanoparticle-producing bacteria may simplify the diagnosis of cancer and other medical conditions.
IDing Cancer with 3-D Genomics
Tracy Vence | May 7, 2014
In a proof-of-principle study, scientists show that the three-dimensional shape of a cancer cell genome can reliably classify subtypes of human leukemia.
Next Generation: Cancer Cell Protein Profiling
Abby Olena | Jan 15, 2014
Antibody barcoding allows scientists and clinicians to analyze protein expression in small amounts of cancer tissue.